Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 106244
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.106244
Figure 7
Figure 7 Decision curve analysis comparing the nomogram and tumor node metastasis staging systems for overall survival. A: 1-year; B: 3-year; C: 5-year. The nomogram provided greater net benefit than tumor node metastasis staging across clinically relevant threshold probabilities (10%-90%), validating its utility for guiding therapeutic decisions. OS: Overall survival; AJCC: American Joint Committee on Cancer.